- Home
- AIP vs AQST Comparison
AIP vs AQST Comparison
Compare AIP & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIP
- AQST
- Stock Information
- Founded
- AIP 2003
- AQST 2004
- Country
- AIP United States
- AQST United States
- Employees
- AIP N/A
- AQST N/A
- Industry
- AIP Semiconductors
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- AIP Technology
- AQST Health Care
- Exchange
- AIP Nasdaq
- AQST Nasdaq
- Market Cap
- AIP 244.1M
- AQST 254.1M
- IPO Year
- AIP 2021
- AQST 2018
- Fundamental
- Price
- AIP $5.82
- AQST $2.51
- Analyst Decision
- AIP Strong Buy
- AQST Strong Buy
- Analyst Count
- AIP 4
- AQST 6
- Target Price
- AIP $12.75
- AQST $11.17
- AVG Volume (30 Days)
- AIP 166.0K
- AQST 1.4M
- Earning Date
- AIP 05-01-2025
- AQST 05-06-2025
- Dividend Yield
- AIP N/A
- AQST N/A
- EPS Growth
- AIP N/A
- AQST N/A
- EPS
- AIP N/A
- AQST N/A
- Revenue
- AIP $57,724,000.00
- AQST $57,561,000.00
- Revenue This Year
- AIP $19.68
- AQST N/A
- Revenue Next Year
- AIP $18.13
- AQST $39.51
- P/E Ratio
- AIP N/A
- AQST N/A
- Revenue Growth
- AIP 7.56
- AQST 13.79
- 52 Week Low
- AIP $5.46
- AQST $2.20
- 52 Week High
- AIP $12.64
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- AIP 33.34
- AQST 41.88
- Support Level
- AIP $5.80
- AQST $2.20
- Resistance Level
- AIP $6.26
- AQST $2.61
- Average True Range (ATR)
- AIP 0.47
- AQST 0.22
- MACD
- AIP 0.00
- AQST -0.03
- Stochastic Oscillator
- AIP 19.83
- AQST 36.47
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.